Palatin Technologies
PTN
#9923
Rank
โ‚น3.52 B
Marketcap
โ‚น2,068
Share price
4.59%
Change (1 day)
2,525.34%
Change (1 year)

Palatin Technologies (PTN) - Total liabilities

Total liabilities on the balance sheet as of March 2025 : โ‚น0.90 Billion

According to Palatin Technologies's latest financial reports the company's total liabilities are โ‚น0.90 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Palatin Technologies - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-06-30โ‚น0.90 B-44.64%
2023-06-30โ‚น1.63 B4.53%
2022-06-30โ‚น1.56 B19.16%
2021-06-30โ‚น1.31 B254.93%
2020-06-30โ‚น0.36 B28.12%
2019-06-30โ‚น0.28 B-65.02%
2018-06-30โ‚น0.82 B-79.41%
2017-06-30โ‚น4.00 B108.66%
2016-06-30โ‚น1.92 B74.83%
2015-06-30โ‚น1.09 B561.04%
2014-06-30โ‚น0.16 B33.16%
2013-06-30โ‚น0.12 B-36.69%
2012-06-30โ‚น0.19 B48.22%
2011-06-30โ‚น0.13 B-6.72%
2010-06-30โ‚น0.14 B-69.88%
2009-06-30โ‚น0.47 B-12.33%
2008-06-30โ‚น0.53 B-45.1%
2007-06-30โ‚น0.98 B-2.47%
2006-06-30โ‚น1.00 B-10.7%
2005-06-30โ‚น1.12 B192.92%
2004-06-30โ‚น0.38 B104.46%
2003-06-30โ‚น0.18 B4.99%
2002-06-30โ‚น0.17 B63.92%
2001-06-30โ‚น0.10 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
MediciNova
MNOV
โ‚น0.26 B-70.67%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
โ‚น0.23 B-74.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚น113.45 B 12,376.77%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
โ‚น81.11 B 8,820.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น47.33 B 5,105.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น10.206 T 1,122,314.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
โ‚น29.83 B 3,180.97%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น6.156 T 676,923.61%๐Ÿ‡ฌ๐Ÿ‡ง UK